ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
39,938.30
0.17%
Gold vs US Dollar
2,406.365
1.18%
Brent Oil
83.455
0.30%
Bitcoin
66,934.06
2.60%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Checkpoint Therapeutics Inc (CKPT)

  7. Checkpoint Therapeutics Inc (CKPT) News

Checkpoint Therapeutics (CKPT)

Checkpoint Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CKPT
DateTimeSourceHeadlineSymbolCompany
17/05/202400:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
14/05/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
10/05/202421:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
10/05/202413:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
02/03/202401:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
05/02/202422:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CKPTCheckpoint Therapeutics Inc
03/02/202401:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
02/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
30/01/202422:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CKPTCheckpoint Therapeutics Inc
30/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
05/01/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
18/12/202312:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
27/11/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CKPTCheckpoint Therapeutics Inc
17/11/202322:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CKPTCheckpoint Therapeutics Inc
17/11/202322:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CKPTCheckpoint Therapeutics Inc
13/11/202322:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
13/11/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
03/10/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202321:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202321:01GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
31/07/202313:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
31/07/202313:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CKPTCheckpoint Therapeutics Inc
27/07/202312:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202322:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202322:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CKPTCheckpoint Therapeutics Inc
15/05/202321:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CKPTCheckpoint Therapeutics Inc
15/05/202321:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CKPTCheckpoint Therapeutics Inc
15/05/202321:01GlobeNewswire Inc.Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
01/05/202321:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CKPTCheckpoint Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CKPT

Your Recent History

LSE
ENET
Ethernity Networks
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
EZJ
Easyjet
LSE
MIN
Minoan
LSE
GKP
Gulf Keystone Petroleum
LSE
CUSN
Cornish Metals
LSE
BIRD
Blackbird
LSE
THG
Thg
LSE
JLP
Jubilee Metals
LSE
AAZ
Anglo Asian Mining
LSE
BP.
Bp
LSE
SRSP
Sirius Petroleum
LSE
CHRY
Chrysalis Investments
LSE
RR.
Rolls-royce
LSE
PXC
Phoenix Copper
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved